Myriad Genetics, Inc. (MYGN)

5.82 +0.06 (+1.04%) USD  |  NASDAQ  |  Oct 23, 16:00
5.835 +0.02 (+0.26%) After-Hours: 20:00
More

Myriad Genetics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for MYGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
September 03, 2026 --
August 03, 2026 --
June 01, 2026 --
May 11, 2026 --
May 07, 2026 --
Date Value
May 06, 2026 --
February 24, 2026 --
November 08, 2024 --
October 10, 2024 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Natera, Inc. --
Labcorp Holdings, Inc. Upgrade
Sera Prognostics, Inc. --
BioRestorative Therapies, Inc. --
CareDx, Inc. --